Pharmacokinetic properties and in-vivo biological activity of recombinant human erythropoietin encapsulated in red blood cells

Cytokine

Volumn 9, Issue 1, 1997, Pages 66-71

  Garin, Marina Inmaculada ^a,b   López, Rosa María ^a   Luque, José ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Anaemia; Delivery cell systems; Pharmacokinetics; Recombinant human erythropoietin; Red blood cells

Indexed keywords

CHROMIUM 51; RECOMBINANT ERYTHROPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; ENCAPSULATION; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; ERYTHROPOIESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; NONHUMAN; POLYCYTHEMIA; PRIORITY JOURNAL;

EID: 0030888168     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0137     Document Type: Article

References (16)

1. 1. Faulds D, Sorkin EM (1989) Epoetin (Recombinant Human Erythropoietin). Drugs 38-6:863-899.
2. 2. Jelkmann W (1992) Erythropoietin: structure, control of production, and function. Physiol Rev 72:449-489.
3. 3. Spivak JL (1993) Recombinant erythropoietin. Annu Rev Med 44:243-253.
4. 4. Magnani M, DeLoach JR (1992) The Use of Resealed Erythrocytes as Carriers and Bioreactors. Plenum Press, New York.
5. 5. DeLoach JR, Way JL (1994) Carrier and Bioreactor red blood cells for drug delivery and targeting, Vol. 92. Great Britain, Advances in the Biosciences. Pergamon.
6. 6. Garin MI, Lopez RM, Sauz S, Pinilla M, and Luque J. (1996) Erythrocytes as carriers for recombinant human erythropoietin. Pharm Res 13:869-874.
7. 7. Garín MI, Kravtzoff R, Chestier N, Sanz S, Pinilla M, Luque J, Ropars C (1994) Density gradient separation of L-asparaginase-loaded human erythrocytes. Biochem Mol Biol Int 33:807-814.
8. 8. Spivak JL (1989) Recombinant human erythropoietin and its clinical application. Interf Cyt 12:11-13.
9. 9. Flaharty KK, Caro J, Erslev A, Whalen JJ, Morris EM, Bjornsson TD, Vlasses PH (1990) Pharmacokinetics and erythropoietic response to recombinant human erythropoietin in healthy men. Clin Pharmacol Ther 47:557-564.
10. 10. Macdougall IC, Roberts DE, Coles GA, Williams JD (1991) Clinical pharmacokinetics of epoetin (recombinant human erythropoietin). Clin Pharmacokinet 20:99-113.
11. 11. Cotes PM, Bangham DR (1961) Bioassay of erythropoietin in mice made polycythemic by exposure to air at a reduced pressure. Nature 191:1065-1067.
12. 12. Goldwasser E, Gross M (1973) Erythropoietin: assay and study of its mode of action. Methods Enzymol 37:109-121.
13. 13. Chiarantini L, Johnson J, DeLoach JR (1991) Optimized recirculation survival of mouse carrier erythrocytes. Blood Cells 17:607-617.
14. 14. Schlegel RA, Lumley-Sapanski K, Williamson P (1992) Single cell analysis of factors increasing the survival of resealed erythrocytes in the circulation of mice. Adv Exp Med Biol 326:133-138.
15. 51Cr as a label of red cells. Br J Haematol 1:62-74.
16. 16. Houwen B (1992) Reticulocyte maturation. Blood Cells 18:167-186.